Am I eligible?
Find out if you can volunteer today.
Am I eligible to participate in the THRIVE-2 Clinical Study?
To participate in the THRIVE-2 Clinical Study, you must:
- Be at least 18 years old.
- Be diagnosed with TED by a physician.
- Have symptoms of chronic TED beginning more than 15 months ago. Symptoms may include discomfort of the eye and eyelids, dry eyes, pain/difficulty moving the eyes, eyelid retraction, bulging eyes, or double vision.
You must NOT:
- Have previously had radiation to treat TED.
- Have previously been treated with Tepezza® (teprotumumab) or another investigational drug for TED.
Who can I contact for more information?
If you or a loved one have been diagnosed with TED and you wish to learn more about THRIVE-2, please find a study site near you to determine if you may be eligible.
For additional information about THRIVE-2 or about the study sponsor, Viridian Therapeutics, please email patientadvocacy@viridiantherapeutics.com